003060.KS
Aprogen Biologics Inc.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 1,727.00
−0.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.12x
- Price / sales
- 0.27x
- Price / cash flow
- -0.71x
Enterprise value
- Enterprise value
- KRW 288.1B
- EV / sales
- 3.34x
- EV / EBITDA
- -10.40x
- EV / EBIT
- -2.43x
- Market cap
- KRW 22.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026